Handumon, Esterlita .
HRN: 06-48-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2022
CEFUROXIME 500MG (TAB)
06/04/2022
06/11/2022
ORAL
1 Tab
BID X 7 Days
SP CS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes